Medexus Pharmaceuticals Inc.

TSX (CAD): Medexus Pharmaceuticals Inc. (MDP)

Last Price

2.66

Today's Change

-0.04 (1.48%)

Day's Change

2.65 - 2.72

Trading Volume

13,920

Overview

Market Cap

65 Million

Shares Outstanding

24 Million

Avg Volume

34,435

Avg Price (50 Days)

2.29

Avg Price (200 Days)

1.95

PE Ratio

53.60

EPS

0.05

Earnings Announcement

06-Nov-2024

Previous Close

2.70

Open

2.72

Day's Range

2.65 - 2.72

Year Range

1.44 - 3.47

Trading Volume

14,720

Price Change Highlight

1 Day Change

-0.74%

5 Day Change

8.94%

1 Month Change

18.06%

3 Month Change

50.56%

6 Month Change

54.91%

Ytd Change

5.10%

1 Year Change

-12.70%

3 Year Change

-21.87%

5 Year Change

-24.08%

10 Year Change

-40.44%

Max Change

-64.27%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a triamcinolone hexacetonide injectable suspension; and Gleolan, an optical imaging agent indicates for patients with glioma symptoms. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals Inc. is based in Bolton, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment